258 related articles for article (PubMed ID: 33678521)
1. Does Reduced Renal Function Predispose to Cancer-specific Mortality from Renal Cell Carcinoma?
Palacios DA; Zabor EC; Munoz-Lopez C; Roversi G; Mahmood F; Abramczyk E; Kelly M; Wilson B; Abouassaly R; Campbell SC
Eur Urol; 2021 Jun; 79(6):774-780. PubMed ID: 33678521
[TBL] [Abstract][Full Text] [Related]
2. Transperitoneal Robot-assisted Partial Nephrectomy with Minimum Follow-up of 5 Years: Oncological and Functional Outcomes from a Single Institution.
Bertolo R; Garisto J; Dagenais J; Sagalovich D; Stein R; Fareed K; Gao T; Armanyous S; Fergany A; Lioudis M; Kaouk J
Eur Urol Oncol; 2019 Mar; 2(2):207-213. PubMed ID: 31017098
[TBL] [Abstract][Full Text] [Related]
3. Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma.
Gershman B; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
Eur Urol; 2018 Dec; 74(6):825-832. PubMed ID: 30262341
[TBL] [Abstract][Full Text] [Related]
4. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
[TBL] [Abstract][Full Text] [Related]
5. Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis.
Patel SH; Uzzo RG; Larcher A; Peyronnet B; Lane BR; Pruthi D; Reddy M; Capitanio U; Joshi S; Noyes S; Eldefrawy A; Ghali F; Meagher MF; Hamilton ZA; Yim K; Nasseri R; Bradshaw AW; Dey S; Kirmiz S; Wan F; Liss MA; Bensalah K; Montorsi F; Derweesh IH
Clin Genitourin Cancer; 2020 Dec; 18(6):e723-e729. PubMed ID: 32600941
[TBL] [Abstract][Full Text] [Related]
6. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?
Capitanio U; Stewart GD; Klatte T; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Zaffuto E; Rodriguez Faba O; Salagierski M; Lingard J; Carini M; Ouzaid I; Mir MC; Montorsi F; Da Pozzo LF; Stief C; Minervini A; Brookman-May SD
Eur Urol Focus; 2018 Dec; 4(6):972-977. PubMed ID: 28753867
[TBL] [Abstract][Full Text] [Related]
7. Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma.
Antonelli A; Minervini A; Sandri M; Bertini R; Bertolo R; Carini M; Furlan M; Larcher A; Mantica G; Mari A; Montorsi F; Palumbo C; Porpiglia F; Romagnani P; Simeone C; Terrone C; Capitanio U
Eur Urol; 2018 Nov; 74(5):661-667. PubMed ID: 30104082
[TBL] [Abstract][Full Text] [Related]
8. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
[TBL] [Abstract][Full Text] [Related]
9. Partial versus radical nephrectomy in very elderly patients: a propensity score analysis of surgical, functional and oncologic outcomes (RESURGE project).
Mir MC; Pavan N; Capitanio U; Antonelli A; Derweesh I; Rodriguez-Faba O; Linares E; Takagi T; Rha KH; Fiori C; Maurer T; Zang C; Mottrie A; Umari P; Long JA; Fiard G; De Nunzio C; Tubaro A; Tracey AT; Ferro M; De Cobelli O; Micali S; Bevilacqua L; Torres J; Schips L; Castellucci R; Dobbs R; Quarto G; Bove P; Celia A; De Concilio B; Trombetta C; Silvestri T; Larcher A; Montorsi F; Palumbo C; Furlan M; Bindayi A; Hamilton Z; Breda A; Palou J; Aguilera A; Tanabe K; Raheem A; Amiel T; Yang B; Lima E; Crivellaro S; Perdona S; Gregorio C; Barbati G; Porpiglia F; Autorino R
World J Urol; 2020 Jan; 38(1):151-158. PubMed ID: 30937569
[TBL] [Abstract][Full Text] [Related]
10. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
[TBL] [Abstract][Full Text] [Related]
11. Predicting Renal Function Outcomes After Partial and Radical Nephrectomy.
Bhindi B; Lohse CM; Schulte PJ; Mason RJ; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 May; 75(5):766-772. PubMed ID: 30477983
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Management of Renal Masses in Solitary Kidneys.
Yasuda Y; Zhang JH; Attawettayanon W; Rathi N; Wilkins L; Roversi G; Zhang A; Accioly JPE; Shah S; Munoz-Lopez C; Palacios DA; Hofmann M; Campbell RA; Kaouk J; Haber GP; Eltemamy M; Krishnamurthi V; Abouassaly R; Martin C; Li J; Weight C; Campbell SC
Eur Urol Oncol; 2023 Feb; 6(1):84-94. PubMed ID: 36517406
[TBL] [Abstract][Full Text] [Related]
13. Impact of worsening surgically induced chronic kidney disease (CKD-S) in preoperative CKD-naïve patients on survival in renal cell carcinoma.
Nguyen MV; Walia A; Saidian A; Puri D; Meagher MF; Hakimi K; Tanaka H; Patil D; Yasuda Y; Saito K; Dhanji S; Cerrato C; Narasimhan R; Perry J; Master V; Fujii Y; Derweesh IH
BJU Int; 2023 Feb; 131(2):219-226. PubMed ID: 35876044
[TBL] [Abstract][Full Text] [Related]
14. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years.
Marchioni M; Preisser F; Bandini M; Nazzani S; Tian Z; Kapoor A; Cindolo L; Abdollah F; Tilki D; Briganti A; Montorsi F; Shariat SF; Schips L; Karakiewicz PI
Eur Urol Focus; 2019 May; 5(3):467-473. PubMed ID: 29398456
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Robot-assisted Partial Nephrectomy for Clinical T3a Renal Masses: A Multicenter Analysis.
Yim K; Aron M; Rha KH; Simone G; Minervini A; Challacombe B; Schips L; Berardinelli F; Quarto G; Mehrazin R; Patel D; Patel S; Bindayi A; Ashrafi AN; Desai M; Alqahtani A; Gallucci M; Sulek J; Mari A; De Luyk N; Anele U; Autorino R; Porpiglia F; Sundaram CP; Gill IS; Perdona S; Derweesh IH
Eur Urol Focus; 2021 Sep; 7(5):1107-1114. PubMed ID: 33249089
[TBL] [Abstract][Full Text] [Related]
17. Oncologic Outcomes of Partial Nephrectomy for Stage T3a Renal Cell Cancer.
Shvero A; Nativ O; Abu-Ghanem Y; Zilberman D; Zaher B; Levitt M; Fridman E; Portnoy O; Ramon J; Dotan ZA
Clin Genitourin Cancer; 2018 Jun; 16(3):e613-e617. PubMed ID: 29174471
[TBL] [Abstract][Full Text] [Related]
18. A Nomogram to Predict Significant Estimated Glomerular Filtration Rate Reduction After Robotic Partial Nephrectomy.
Martini A; Cumarasamy S; Beksac AT; Abaza R; Eun DD; Bhandari A; Hemal AK; Porter JR; Badani KK
Eur Urol; 2018 Dec; 74(6):833-839. PubMed ID: 30224195
[TBL] [Abstract][Full Text] [Related]
19. Patients with high nuclear grade pT1-ccRCC are more suitable for radical nephrectomy than partial nephrectomy: a multicenter retrospective study using propensity score.
Xu H; Xing Z; Ai K; Wang J; Lv Z; Deng H; Li K; Wang Y; Li Y
World J Surg Oncol; 2024 Jan; 22(1):24. PubMed ID: 38254091
[TBL] [Abstract][Full Text] [Related]
20. Impact of comorbidities on acute kidney injury and renal function impairment after partial and radical tumor nephrectomy.
Wenzel M; Kleimaker A; Uhlig A; Würnschimmel C; Becker A; Yu H; Meyer CP; Fisch M; Chun FKH; Leitsmann M
Scand J Urol; 2021 Oct; 55(5):377-382. PubMed ID: 34427540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
